Andrew R Robbins insider trades

Open-market stock purchases and sales by Andrew R Robbins, President and CEO at Cogent Biosciences, Inc, from SEC Form 4 filings since Dec 27, 2016.

Recent trades

DateStockTradeValue
May 19, 2026COGT Cogent Biosciences, IncBought (not open market)—
Dec 17, 2025COGT Cogent Biosciences, IncBought (not open market)—
Dec 17, 2025COGT Cogent Biosciences, IncBought (not open market)—
Dec 17, 2025COGT Cogent Biosciences, IncSold (not open market)$14.5M
Dec 17, 2025COGT Cogent Biosciences, IncBought (not open market)—

Companies traded

  • COGT Cogent Biosciences, Inc: other filings, last May 19, 2026
  • HARP Harpoon Therapeutics, Inc: other filings, last Mar 11, 2024
  • ARRY Array Biopharma Inc: 3 sales, last Jul 30, 2019

Get free alerts when Andrew R Robbins files a new trade →